427 results on '"Deutsch, Melanie"'
Search Results
2. Successful therapy with tenofovir disoproxil fumarate (TDF) in patients with chronic hepatitis B (CHB) does not guarantee amelioration of liver damage assessing by transient elastography. A retrospective - prospective multicenter study
3. Autoimmune polyglandular syndrome with shock and high anion gap metabolic acidosis
4. Contributors
5. Vasculitides and Hepatitis C Infection
6. Urine Nephrin and Podocalyxin Reflecting Podocyte Damage and Severity of Kidney Disease in Various Glomerular Diseases—A Cross-Sectional Study
7. WED-503 Liver stiffness measurement before and after antiviral treatment for hepatitis C: results from an OST-based hepatology service facility
8. WED-403 HEllenic multicenter ReAl-life CLInical Study for bulevirtide therapy in chronic hepatitis D (HERACLIS_BLV_D)
9. THU-398 Metabolic factors predict significant liver fibrosis in people who use drugs (PWUD) and general population with HCV infection. Time to re-consider the follow-up strategy in chronic hepatitis C patients
10. Urine Nephrin and Podocalyxin Reflecting Podocyte Damage and Severity of Kidney Disease in Various Glomerulonephritis. A Cross-Sectional Study
11. Assessment of dietary habits and the adequacy of dietary intake of patients with cirrhosis-the KIRRHOS study
12. A Current Synopsis of the Emerging Role of Extracellular Vesicles and Micro-RNAs in Pancreatic Cancer: A Forward-Looking Plan for Diagnosis and Treatment
13. Addition of Dulaglutide or Empagliflozin to Standard-of-Care Treatment: Effect on Liver Steatosis in Patients With Type 2 Diabetes Mellitus
14. The Arising Role of Extracellular Vesicles in Cholangiocarcinoma: A Rundown of the Current Knowledge Regarding Diagnostic and Therapeutic Approaches
15. Wilson disease: 30-year data on epidemiology, clinical presentation, treatment modalities and disease outcomes from two tertiary Greek centers
16. Persistence and adherence to nucleos(t)ide analogues in chronic hepatitis B: a multicenter cohort study
17. Can Hepatitis B Virus (HBV) Reactivation Result from a Mild COVID-19 Infection?
18. Can Hepatitis B Virus (Hbv) Reactivation Be the Result of a Mild COVID-19 Infection With No Need of Systemic Immunosuppressive Therapy?
19. Autoimmune hepatitis (AIH) in Greece: first results from the Hellenic autoimmune liver diseases study group of the Hellenic association for the study of the liver (HASL)
20. Incidence and associations of HCV reinfection in the era of direct acting antivirals
21. Differences in baseline characteristics of direct acting antiviral (DAA)- treated Greek HCV patients according to source of infection
22. Prevalence and predictors of HDV viremia in anti-HDV positive patients of the HEllenic multicenter ReAl-life CLInical Study (HERACLIS-HDV)
23. Chapter 18 - Vasculitides and Hepatitis C Infection
24. The changing epidemiology of hepatocellular carcinoma in Greece
25. Editorial: Viral hepatitis elimination: Still a big challenge: Care is not only for C.
26. Adherence to the Mediterranean diet is associated with the severity of non-alcoholic fatty liver disease
27. HERACLIS‐HDV cohort for the factors of underdiagnosis and prevalence of hepatitis D virus infection in HBsAg‐positive patients.
28. The Emerging Role of Extracellular Vesicles and Autophagy Machinery in NASH—Future Horizons in NASH Management
29. Hepatitis C Virus Infections in Patients with Hemophilia: Links, Risks and Management
30. Hepatitis B s antigen kinetics during treatment with nucleos(t)ides analogues in patients with hepatitis B e antigen‐negative chronic hepatitis B
31. Two-year safety and efficacy of tenofovir alafenamide in chronic hepatitis B: a HEllenic multicenter ReAl-life CLInical Study (HERACLIS-TAF)
32. HERACLIS‐TAF: a multi‐centre prospective cohort study on 2‐year safety and efficacy of tenofovir alafenamide in patients with chronic hepatitis B with renal and/or bone disorders or risks
33. Sa1655 AWARENESS OF THE DIAGNOSIS AND TREATMENT IN PATIENTS WITH CHRONIC HEPATITIS B (CHB): A REAL LIFE PARADIGM IN THE ERA OF VIRAL HEPATITIS ELIMINATION
34. Hepatitis C Virus Infections in Patients with Hemophilia: Links, Risks and Management
35. The changing epidemiology of hepatocellular carcinoma in Greece
36. Efficacy of prophylactic antiviral therapy and outcomes in HBsAg-negative, anti-HBc-positive patients receiving chemotherapy: a real-life experience
37. Prevalence of Hepatitis B Serum Markers in Young Military Recruits in Greece: A Comparison Study between 2005 and 2019 Cohorts
38. On-treatment prediction of sustained response to peginterferon alfa-2a for HBeAg-negative chronic hepatitis B patients
39. Anticoagulation in patients with atrial fibrillation and liver cirrhosis.
40. Vasculitides and Hepatitis C Infection
41. Contributors
42. Kinetics of quantitative hepatitis B surface antigen in patients with rheumatic disease and chronic hepatitis B receiving biologic agents
43. Adverse drug reactions as a cause of hospital admissions: A 6-month experience in a single center in Greece
44. Editorial: Can dietary gluten restriction improve hepatic steatosis?
45. Sa323 HCV REINFECTION AFTER SUCCESSFUL TREATMENT WITH DIRECT-ACTING ANTIVIRAL THERAPY (DAA) IN PEOPLE WHO INJECT DRUGS (PWID)
46. Sa314 PREDICTORS OF LIVER STIFFNESS CHANGES IN CHRONIC HEPATITIS B (CHB) PATIENTS UNDER LONG-TERM THERAPY WITH TENOFOVIR DISOPROXIL FUMARATE (TDF)
47. Sa325 THE EFFECT OF DIRECT ACTING ANTIVIRAL (DAA) THERAPY ON THE QUALITY OF LIFE (QOL) OF PATIENTS WITH CHRONIC HEPATITIS C (CHC) WHO ATTEND OPIOID SUBSTITUTION (OST) PROGRAMS IN GREECE
48. Minor league offenders strike out in the major league: California's improper use of juvenile adjudications as strikes.
49. THU-196 - Differences in baseline characteristics of direct acting antiviral (DAA)- treated Greek HCV patients according to source of infection
50. THU-197 - Incidence and associations of HCV reinfection in the era of direct acting antivirals
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.